Furthermore, the investigation unveiled a novel potent TRIB3 inhibitor, hesperidin, capable of inducing ferroptosis and demonstrating antitumor effectiveness in HNSCC. Here, TRIB3 is linked to head and neck squamous cell carcinoma.